Abstract
Graphical abstract
Abstract
This study was carried out to investigate whether repeated controlled ovarian hyperstimulation (COH) affects ovarian reserve. For this reason, we aimed to show possible changes in the expression of PTEN and FOXO3, which are involved in preserving the over-reserve, after applying the COH protocol methods. For this purpose, 18 young Wistar albino female rats (8 weeks old) were randomly assigned as group 1 (control), group 2, and group 3 as 6 subjects in each group. Experimental groups were treated with 10 IU/0.1 mL pregnant mare’s serum gonadotropin and a COH protocol consisting of 10 IU/0.1 mL human chorionic gonadotropin injection after 48 h. This procedure was applied three and five times to group 2 and group 3, respectively. For the control groups, the same procedures were performed with 0.1 mL of 0.9% sodium chloride solution. At the end of the experiment, the ovarium tissues were placed in a 10% neutral formaldehyde solution for light microscopic examinations. In histological sections stained with hematoxylin and eosin, the number of ovarian follicles was determined using the physical dissector method. However, the expression of PTEN, FOXO3, and LH-R molecules was evaluated by immunohistochemical methods. As a result of our study, it was concluded that COH administration reduces the expression levels of PTEN and FOXO3 proteins and LH-R, which are among the essential components of the PIK3 intracellular signaling pathway and also increased the levels of hormones such as follicle-stimulating hormone, estradiol, and luteinizing hormone, which are over-reserve markers, and causes adverse effects on the histological structure, oocyte morphology, and number of ovaries.
Lay summary
Today, approximately 10–15% of couples experience fertility problems. However, assisted reproductive techniques help people with fertility problems to get pregnant. The main purpose of these techniques is to put the sperm and egg together outside the woman’s body where the eggs are fertilized and then to return the fertilized eggs (embryos) to the womb. During a woman’s menstrual cycle, several hormones influence the growth of the eggs. This process can be mimicked by using various medications. Medication is given to increase the number of eggs that develop. However, this method is not the same as normal ovulation. Therefore, in our study, we wanted to examine the effect that developing multiple follicles has on the number and quality of eggs remaining for the future.
Introduction
Controlled ovarian hyperstimulation (COH) is the technique of developing a large number of follicles in the same cycle to obtain the most ideal number and quality of oocytes from the ovaries in assisted reproductive techniques (ART). COH has become an indispensable part of ART in our present day with the increase in infertility cases (Siristatidis & Bhattacharya 2007). For this reason, the effects of hyperstimulation on the human body have recently attracted the attention of many researchers. One of the most important parameters that should be considered in ART is ovarian reserve. The activation of primordial follicles, which represent the ovarian reserve, is under the control of suppressive and activating factors (Adhikari et al. 2009, 2010). One of the intracellular signaling pathways that involve these factors is the PI3K signaling pathway. An irregularity in the expression of PTEN, which is one of the main components of the PI3K signaling pathway and which is considered to be a potential protector of the ovarian reserve, causes the primordial follicle pool to be activated earlier. Such a rapid and massive activation of all primordial follicles inevitably ends up in the premature depletion of the follicle pool and results in premature ovarian failure and premature menopause (Goto et al. 2007, Ouyang et al. 2013, Wang et al. 2016). Despite the developments in ART, most patients require multiple COH administrations to achieve pregnancy. This has raised the question of whether repeated COH applications will affect the ovarian reserve of the patient. For this reason, in our study, our purpose was to show possible changes in the expression of PTEN and FOXO3A, which act as suppressor molecules in the transition from primordial follicle to the primary follicle, after COH protocol methods were applied.
Materials and methods
Animals and experimental design
The whole experimental study was conducted with the permission numbered G.Ü.ET-17.027/2017 issued by Gazi University, Animal Experiments Local Ethics Committee. In our study, 18 female adult (8 weeks old) Wistar albino rats were obtained from Animal Breeding and Experimental Research Center (GÜDAM), Gazi University Laboratory. All animals were maintained with a 12 h light/12 h darkness schedule in the laboratory at a controlled temperature of 23 ± 2°C and were fed with a standard rat diet (Korkuteli Food Industry, Turkey) ad libitum. Rats that had normal estrus cycles after vaginal cytologic examination were included in the study (Marcondes et al. 2002). The experimental animals were divided into three different groups by randomly selecting six rats for each group.
-
Group 1: Control group (n = 6)
-
Group 2: Experimental group with three repetitions of COH (n = 6)
-
Group 3: Experimental group with five repetitions of COH (n = 6)
Preparation and administration of gonadotropins
To stimulate folliculogenesis, in the experimental group, follicle-stimulating hormone (FSH) analog pregnant mare’s serum gonadotropin (PMSG, Cat: HOR-272, Prospec, 5 IU/0.1 mL) was injected, and 48 h after this injection, human chorionic gonadotropin (hCG, Cat: C1063-1VL, Sigma, 5 IU/0.1 mL) was administered with i.p injections. PMSG and hCG were dissolved in 100 IU/mL in sterile water for injection before each administration (Quintana et al. 2008, Liang et al. 2009). This procedure was repeated at 1-week intervals, 3 and 5 times to group 2 and group 3, respectively (Xie et al. 2016). The rats in the control group were given 0.1 mL 0.9% NaCl solution instead of PMSG to experience the same stress, and after 48 hours, 0.1 mL 0.9% NaCl solution was given instead of hCG. All rats were sacrificed 1 week after the last injection. At the end of the experiment, all animals were sacrificed under ketamine (45 mg/kg, i.m.) and xylazine (5 mg/kg, i.m.) anesthesia. The ovaries and gonadal fat pads were weighed. After dry weights of the ovary tissues were measured, tissues were first fixed for 72 h in a 10% neutral formaldehyde solution for light microscopic examination, and paraffin blocks were obtained using routine procedures.
Histological analyses of ovarian tissues
Four-micrometer-thick sections were acquired from the ovarian paraffin blocks of all groups. The ovarian full-thickness sections were prepared for hematoxylin and eosin (H&E) and immunohistochemical (IHC) staining. Every one out of four ovarian sections was used for follicular counting after being stained with H&E with the previously reported method (Kalem et al. 2018). IHC staining was performed on ovarian sections with PTEN, FOXO, and LH-R antibodies. Briefly, six zones (one central and five peripheral) were determined randomly from each ovarian tissue sections (5 μm thickness). In these zones, the density of immunoreactivity and the specific pathological criteria of the follicular structures were evaluated under the light microscope.
Morphological classification of ovarian follicles
The sections were stained with H&E, and follicles were counted based on the following criteria: ‘Primordial follicles’ were defined as an oocyte surrounded by a layer of squamous granulosa cells. ‘Unilaminar primary follicles’ were defined as an oocyte surrounded by a single layer of cuboidal granulosa cells. ‘Multilayer primary follicles’ possessed more than one layer of cuboidal granulosa cells, with no visible antrum, and finally, ‘antral follicles’ contain a clearly defined antral space. In addition, the oocyte-free structures which had a large antral cavity and usually possessed a single layer of cuboidal granulosa cells were defined as cystic follicles (Cheong et al. 2014).
Determination of primordial and primary follicular numbers in the ovary
In our study, the numbers of primordial and primary follicles were determined by using a physical dissector method according to Myers et al. (2004) and Altunkaynak et al. (2016).
IHC staining for PTEN, FOXO, and LH-R
Four-micrometer-thick ovarian sections were incubated at 37°C overnight and then at 57°C for 1 h to facilitate deparaffinization. To complete the deparaffinization process, the sections were incubated in xylol twice for 20 min. Then, the sections were dehydrated by incubation in a graded ethanol series (100, 96, 80, 70, and 60%) for 3 min each and then washed with distilled water twice for 5 min each. Sections were fixed in citrate buffer (pH 6.0) (Cat: AP-9003-500, Lot: BBI120127, Lab Vision, Fremont, CA, USA) in a microwave at 750 W for 10 min to ensure that the receptor sites are uncovered from formaldehyde. After cooling to 25°C, the sections were washed with distilled water twice for 5 min each. Tissues on cross sections were circled with a Pap pen. The tissues were then washed with PBS(Cat: AP-9009-10, Lab Vision, Thermo Scientific) (pH 7.4) 3 times for 3 min each followed by treatment with 3% H2O2 for 15 min (Cat: TA-125-HP, Lot: HP41515, Lab Vision) to block the endogenous peroxidase activity. Next, slides that were washed with PBS three times were treated with Ultra-V block (Cat: TA-125-UB, Lot: AUB161208AI, Lab Vision, Thermo Scientific) to prevent any unwanted interactions. The tissues were then subjected to either PTEN (Cat: ab3139, Lot: GR62840-19, Abcam), FOXO3 (Cat: ab23683, Lot: GR314636-1, Abcam), or LH-R (Cat: bs-6431R, Lot: AD080753, Bioss) primary antibody at 4°C overnight. After incubation, slides (washed with PBS) were treated with a biotinylated secondary antibody.
Slides (washed with PBS) were then treated with streptavidin peroxidase for 20 min to achieve enzyme and biotin link. Finally, nuclear staining was achieved using DAPI. Hematoxylin was used as background staining, and the slides were closed using Entellan. Images were taken on a Leica DCM 4000 computer-aided imaging system and evaluated in Leica Q Vin 3 program.
Evaluation of PTEN, FOXO, and LH-R expressions in ovarian sections
PTEN, FOXO, and LH-R expressions were scored using an immune reactive scoring scale and evaluated by two researchers who did not have any prior knowledge of the groups of rats. Accordingly, six zones (one central and five peripheral) were selected from ovarian tissue sections (5 μm thickness) and subjected to IHC staining with PTEN, FOXO, and LH-R antibodies. The HSCORE, defined later, was used to evaluate the immune reactive density in these zones. The HSCORE was determined by the following formula: HSCORE ¼ Pi (i + 1), where ‘i’ is the intensity of labeling with a value of 0, 1, 2, or 3 (none, weak, moderate, or strong) and Pi is the percentage of labeled cells for each intensity, within a range of 0–100%. The rate of positive cells was scored by the extent of immunostaining and was assigned to one of the following categories: 0 (0%, no positive cells), 1 (≤30% positive cells), 2 (30–60% positive cells), and 3 (>60% positive cells) (Ishibashi et al. 2003).
Hormonal analysis
Blood samples were drawn intracardially into plain tubes without heparin for endocrine and biochemical analyses, and sera were separated by centrifugation at 1000 g + 4°C for 10 min. Separated serum samples were placed in polypropylene tubes in small portions and stored at −80°C until analysis.
ELISA method
Serum FSH, luteinizing hormone (LH), and estradiol (E2) levels were estimated by ELISA. FSH, LH, and E2 analyses were performed using serum FSH (Cat: E-EL-R0391, Lot: AK0017SEP22050, Elabscience Biotechnology Inc., Houston, TX, USA), LH (Cat: E-EL-R0026, Lot: AK0017SEP18050, Elabscience Biotechnology Inc., USA), and E2 (Cat: E-EL-R0065, Lot: AK0017SEP18051, Elabscience Biotechnology Inc., USA) rat ELISA kit. Investigators who were blinded to the sample groups performed all analyses.
Statistical analyses
The agreement of the continuous variables with normal distribution was examined graphically and by using the Shapiro–Wilk test. Mean ± s.d., minimum and maximum values, and median (interquartile range) values were used to identify the changes. The variables that met the parametric test assumptions (i.e. primary follicle, Graafian follicle, and cystic structures) were evaluated with the one-way ANOVA. When a difference was detected in the ANOVA result, the source of this difference was investigated by using the Bonferroni post hoc test. The Kruskal–Wallis test was used to compare the non-parametric variables between the groups (primordial follicle and antral follicle counts, and pTEN, FOXO3, and LH-R expressions). When a difference was detected, post hoc pairwise comparisons were made with the Mann–Whitney test and Bonferroni correction to identify the different groups. The statistical analysis and calculations were performed with IBM SPSS Statistics 21 (IBM). In statistical terms, P ≤ 0.05 was taken as an indicator of significant difference.
Results
H&E staining findings
Healthy follicles at different developmental stages, corpus luteum, and a small number of atretic follicles were observed in the ovarian cortex of the control group. All components of connective tissue under the germinal epithelium and the medulla were in normal histological structure (Fig. 1A and B). In group 2, it was observed that the corpus luteum structures had increased considerably and the cortex was almost filled with new and regressed corpus luteum structures. The primordial follicles located under the germinal epithelium were mostly normal structures, but almost all follicles from the monolayer primary follicle were in atretic form and some of them had hemosiderin accumulation (Fig. 1C and D). Cystic formations, increased hemosiderin accumulation in connective tissue, atretic follicles, and corpus luteum were observed in group 3 as well. Additionally, diffuse lymphocyte infiltration was quite common below the germinal epithelium, and cortex and medulla in groups 2 and 3 (Fig. 1E and F).
Follicle counting findings
It was observed that the numbers of primordial follicles were statistically significantly decreased in group 3 compared to the control (P < 0.05). No statistically significant differences in the number of primordial follicles were found between group 1 and group 2 (P = 0.136) and group 2 and group 3 (P = 0.198). The number of total primary follicles showed a statistically significant increase in groups 2 and 3 compared to the control (P < 0.05). However, the number of multilaminar atretic primary follicles was significantly increased in group 3 compared to the control (P < 0.05). When the total number of secondary follicles was evaluated, there was no significant difference between the groups (P = 0.077). Statistically significant decrease in the number of healthy antral follicles was found in groups 2 and 3 (P < 0.05). However, when the number of atretic antral follicles was evaluated, it was seen that this number was significantly lower in the control group compared to group 3 (P < 0.05). The number of Graaf follicles was significantly decreased in group 3 compared to the control (P < 0.05). No statistically significant differences in the number of Graaf follicles were found between groups 1 and 2 (P = 0.002) and groups 2 and 3 (P = 0.347). The number of cystic formation was statistically significantly increased in groups 2 and 3 compared to the control (P < 0.05). In addition, the corpus luteum formations were mostly found in group 2 compared to groups 1 and 3. In addition, the corpus luteum formations were mostly found in group 2 compared to groups 1 and 3. The results are shown in Table 1.
Comparison of follicular count in all groups.
Group 1 (n = 6) | Group 2 (n = 6) | Group 3 (n = 6) | P value | ||||
---|---|---|---|---|---|---|---|
Mean ± s.d. | Median (min–max) | Mean ± s.d. | Median (min–max) | Mean ± s.d. | Median (min–max) | ||
Primordial follicle | 1967.83 ± 96.28 | 1963.00 (1806.00–2090.00) | 1243.33 ± 79.68 | 1221.00 (1144.00–1354.00) | 1060.16 ± 67.07 | 1034.50 (1002.00–1165.00) | 0.001b |
Unilaminar primary follicle | 274.66 ± 46.81 | 254.00 (232.00–346.00) | 453.33 ± 47.86 | 488.00 (369.00–520.00) | 515.16 ± 56.29 | 511.50 (453.00–589.00) | <0.001a |
Multilaminar healthy primary follicle | 71.66 ± 5.81 | 69.00 (66.00–79.00) | 73.16 ± 5,60 | 74.00 (64.00–80.00) | 75.66 ± 5.31 | 74.50 (47.00–85.00) | 0.474a |
Multilaminar atretic primary follicle | 2.33 ± 0.52 | 2.00 (2.00–3.00) | 12.33 ± 1.03 | 12.00 (11.00–14.00) | 15.66 ± 1.03 | 16.00 (14.00–17.00) | <0.001b |
Healty antral follicle | 50.16 ± 3.06 | 50 (46.00–54.00) | 70.50 ± 8.09 | 72.50 (60.00–87.00) | 67.33 ± 5.98 | 68.50 (58.00–73.00) | <0.001a |
Atretic antral follicle | 2.33 ± 5,51 | 2.00 (2.00–3.00) | 9.6 ± 2.33 | 9.50 (6.00–13.00) | 14.00 ± 1.78 | 14.50 (11.00–16.00) | 0.001b |
Graaf follicle | 3.16 ± 0.75 | 3.00 (2.00–4.00) | 1.50 ± 0.54 | 1.50 (1.00–2.00) | 0.83 ± 0.75 | 1.00 (0.00–2.00) | <0.001a |
Cyst | 2.16 ± 0.75 | 2.00 (1.00–3.00) | 7.83 ± 1.16 | 8.00 (6.00–9.00) | 11.16 ± 1.60 | 11.00 (9.00–13.00) | <0.001a |
aOne-way ANOVA, bKruskal–Wallis test.
IHC findings
PTEN findings
The immunoreactivity levels of PTEN and FOXO3 in primordial follicles and LH-R in antral and Graaf follicles were evaluated in all groups using the H-Score method and compared statistically. The results are shown in Table 2. PTEN immunoreactivity was evaluated in the oocytes, granulosa cells, and theca cells of the follicles at every stage of follicular development. In the control group, as the fo∅llicles grew, PTEN expression increas∯ed in granulosa c≛ells but decreased in the≼ oocyte cytoplasm (Fig. 2A and B). Compared with the control group, PTEN expression was signi≼ficantly decreased in the oocyte∀ cytoplasm at every stage of follicular development in groups 2 (Fig. 2C and D) and 3 (Fig. 2E and F). Also, it almost disappeared in granulosa cells. The differences between groups 1 and 2 (P < 0.05), and groups 1 and 3 (P < 0.05) were statistically significant. This finding was consistent with the decreasing number of primordial follicles in groups 2 and 3. Additionally, there were no statistically significant differences in PTEN expression when groups 2 and 3 were compared (P = 0.162).
Comparison of PTEN, FOXO3, and LH-R expression in all groups.
Group 1 (n = 6) | Group 2 (n = 6) | Group 3 (n = 6) | P value | ||||
---|---|---|---|---|---|---|---|
Mean ± s.d. | Median (min–max) | Mean ± s.d. | Median (min–max) | Mean ± s.d. | Median (min–max) | ||
PTEN | 2.77 ± 0.42 | 3.00 (2.00–3.00) | 1.36 ± 0.68 | 1.00 (000–2.00) | 0.94 ± 0.58 | 1.00 (0.00–2.00) | <0.001b |
FOXO3 | 2.77 ± 0.43 | 3.00 (2.00–3.00) | 1.61 ± 0.68 | 2.00 (0.00–2.00) | 0.94 0.58 | 1.00 (0.00–2.00) | <0.001b |
LH-R | 2.75 ± 0.43 | 3.00 (2.00–3.00) | 0.88 ± 0.66 | 1.00 (0.00–2.00) | 0.41 ± 0.50 | 0.00 (0.00–1.00) | <0.001b |
bKruskal–Wallis test.
FOXO3 findings
The immunoreactivity of FOXO3 was evaluated in the oocytes, granulosa cells, and theca cells of the follicles at every stage of follicular development. In the control group, FOXO3 expression was found to be strong in the oocyte belonging to the primordial follicle but weak in the granulosa cells of the follicle. As the follicles grew, FOXO3 expression increased in granulosa cells but decreased in the oocyte cytoplasm (Fig. 3A and B). Compared with the control group, FOXO3 expression was significantly decreased in the oocyte cytoplasm at every stage of follicular development in groups 2 (Fig. 3C and D) and 3 (Fig. 3E and F). Also, it almost disappeared in granulosa cells. The differences between groups 1 and 2 (P < 0.05), and groups 1 and group 3 (P < 0.05) were statistically significant. This finding was consistent with the amount of PTEN expression in the oocyte cytoplasm and the number of primordial follicles. Additionally, there were no statistically significant differences in FOXO3 expression when groups 2 and 3 were compared (P = 0.006).
LH-R findings
In the ovary, the immunoreactivity of LH-R, which is expressed in theca interna and granulosa cells of antral and Graaf follicles and corpus luteum structures, was evaluated in all experimental groups. In the control group, LH-R expression was found to be strong in theca interna and granulosa cells of antral and Graaf follicles (Fig. 4A). In contrast, it almost disappeared in theca interna and granulosa cell cytoplasm of Graaf follicles, antral follicles, and corpus luteum in groups 2 (Fig. 4B) and 3 (Fig. 4C). There were no statistically significant differences in LH-R expression in the oocyte cytoplasm when groups 2 and 3 were compared (P = 0.134). Whereas, the differences between groups 1 and 2 (P < 0.05), and groups 1 and 3 (P < 0.05) were statistically significant.
ELISA results
E2 level was observed to be increased in groups 2 and 3 compared to the control group, but the difference between groups was not statistically significant (P = 0.370 and P = 0.115, respectively). LH and FSH level was found to be increased in groups 2 and 3 compared to the control group, especially in group 2. Although the difference in LH level between control and group 3 was not statistically significant (P = 0.976), the difference between groups 1 and 2 (P < 0.05) and groups 2 and 3 (P < 0.05) was statistically significant. Despite the difference in FSH level between control and group 2 was statistically significant (P < 0.05), there was no statistically significant difference observed between groups 1 and 3 (P = 0.864), and groups 2 and 3 (P = 0.148). All statistical results are shown in Table 3.
Comparison of E2, LH, and FSH expression in all groups.
Group 1 (n = 6) | Group 2 (n = 6) | Group 3 (n = 6) | P value | ||||
---|---|---|---|---|---|---|---|
Mean ± s.d. | Median (min–max) | Mean ± s.d. | Median (min–max) | Mean ± s.d. | Median (min–max) | ||
E2 | 60.00 ± 1.21 | 60.50 (42.00–5.00) | 70.83 ± 1.14 | 69.00 (57.00–88.00) | 74.83 ± 9.19 | 71.50 (67.00–90.00) | 0.085a |
LH | 64.00 ± 1.61 | 64.00 (38.00–88.00) | 97.66 ± 1.05 | 94.50 (88.00–110.00) | 67.66 ± 1.73 | 67.00 (48.00–90.00) | 0.003a |
FSH | 18.50 ± 5.99 | 19.50 (9.00–25.00) | 42.50 ± 1.50 | 47.50 (18.00–56.00) | 23.38 ± 1.50 | 23.00 (5.80–42.00) | 0.013a |
aOne-way ANOVA
Discussion
Some extracellular matrix components and growth factors that act in an autocrine-paracrine manner play role in the growth process of the ovarian follicles, which are the functional units of ovaries (Eppig 2001, Skinner 2005, Li et al. 2010, Pan et al. 2012). One of the most important mechanisms regarding primordial follicle activation is the PI3K signaling pathway (Hsueh et al. 2015). The molecules that are the components of this signaling pathway and which are considered to play roles in the regulation of follicle population dynamics are mainly PI3K, PIP2, PIP3, PDK-1, Akt, p27, TSC, mTOR, Foxo3a, and PTEN (Accili & Arden 2004, Kalich-Philosoph et al. 2013). PTEN, which is the negative regulator of the PI3K signaling pathway, works synergistically in coordination with the other molecules in this signaling pathway and suppresses the growth of primordial follicles protecting the ovarian reserve. Increased PTEN expression suppresses the expression of AKT, which plays role in many important pathways such as cell cycle, apoptosis, growth, and differentiation. In mammals, Akt inhibits p27, which is responsible for cell cycle arrest in the G1 phase and which is one of the most important suppressors in the transition from primordial follicle to the primary follicle, and early activation is thus seen in primordial follicles (Kiyokawa et al. 1996, Tong et al. 1998).
FOXO3 is a transcription factor expressed highly in the oocyte nucleus in primordial follicles playing roles in maintaining the ovarian reserve. In mice, it is known that decreased FOXO3 expression induces apoptosis in primordial follicles and reduces the ovarian reserve (Richards et al. 2002). In a similar study conducted with rodents, it was shown that oocyte-specific deletion of PTEN, Tsc1, and Foxo3a genes causes mass activation of dormant primordial follicles (Novella-Maestre et al. 2015). Although KOH is a technique that has been applied for years, no study has been found in the literature examining the effect of repeated KOH applications on ovarian reserve through the PI3K signal pathway. In line with these data, we hypothesized that the suppression mechanism of follicular growth may be impaired as one of the possible causes of primordial follicle loss that may occur in the ovarian reserve after KOH administration to rats in adulthood.
Therefore, in our study, we aimed to show possible changes in the expression of PTEN and FOXO3A, which act as suppressor molecules in the transition from primordial follicle to primary follicle, after applying KOH protocol methods, by immunohistochemical and biochemical methods.
When the study results were evaluated, PTEN and FOXO3 expressions were found to be higher in the control group compared to groups 2 and 3. Compared with the control group, PTEN and FOXO3 expression was significantly reduced in the oocyte cytoplasm at all stages of follicular development in groups 2 and 3. In addition, when groups 2 and 3 were compared, there was no statistically significant difference in PTEN and FOXO3 expression. In line with these data, we believe that decreased primordial follicle pool and expression of PTEN and FOXO3 molecules in our study were directly proportional in the groups that were treated with KOH. With the decrease of PTEN and FOXO3 expressions after KOH applications, the balance of the mechanism or mechanisms protecting the primordial follicle pool may be disturbed. The data of our study also support this situation.
Although the early stages of follicular development, which is a dynamic process, occur independently of gonadotropins, FSH and LH have very important effects on the selection of one single dominant follicle from the activated follicle group. For this reason, the interaction between gonadotropins and their receptors plays vital roles in the functioning of the female reproductive system (Yamoto et al. 1992, Zhang et al. 2001, Jeppesen et al. 2012). In humans, the expression of FSH-R is initiated at the multilayered primary follicle stage, on the surface of granulosa cells with the appearance of theca cells, and increases toward antral follicle (Minegishi et al. 1990, 1991, Zhang et al. 2001). FSH uses several intracellular signaling pathways, which include PI3K, to stimulate granulosa cells by interacting with FSH-R (Gonzalez-Robayna et al. 2000). In the literature, there are studies reporting that FSH activates PI3K signaling pathway during the follicular maturation process (Maizels et al. 1998, Alam et al. 2004) and any irregularity in this signaling pathway results in increased follicular atresia along with impaired steroid hormone synthesis (Chitnis et al. 2009). More than 100 target genes are activated, which play roles in the proliferation, growth, and differentiation of granulosa cells as a response to the mural granulosa cells that are stimulated by FSH. One of these genes is LH-R. Follicles must have a sufficient number of LH-Rs for a healthy progression to ovulation (Hobbs et al. 2012, Gong et al. 2019). It was emphasized in several studies in the past that LH-R expression is necessary for oocyte maturation, ovulation, and luteinization (Hunzicker-Dunn & Maizels 2006).
Zhang et al. in a study with LH-R knockout mice reported a delay in the formation of small ovaries, thin uterus, and vaginal opening in these mice compared to the control. In another study, it was reported that antral follicle formation was observed in the ovaries of LH-R knockout mice, but preovulatory follicle and KL formation were not observed. In this study, it was observed that follicular development did not go beyond the antral follicle even when the follicles were stimulated with high doses of FSH, and it was emphasized that LH-R is indispensable for follicular maturation (Yu et al. 2005, Hunzicker-Dunn & Maizels 2006).
In our study, it was also observed that LH-R expression was reduced at significant levels in the groups that were administered repeated KOH compared to the controls. We believe that this decrease in LH-R expression might have occurred because of the dysregulation caused by KOH administration in PIK3 signaling pathway. The findings such as decreased PTEN and FOXO3 molecule expressions, which are the main components of the PIK3 signaling pathway, obtained in our study, also support this.
In studies reported in the literature, increased E2 and FSH levels on the third day of the menstrual cycle are reported to indicate poor ovarian reserve (Mukherjee et al. 1996, Chuang et al. 2003). In our study, it was also found that the FSH, LH, and E2 levels were found to have increased in the groups that were treated with KOH compared to the controls. These data obtained in the study were also consistent with the findings of decreased primordial follicle number and decreased PTEN, FOXO3, and LH-R expression in these groups.
As a conclusion, it was determined in the present study that repeated COH reduced the expression levels of PTEN and FOXO3 proteins, which are known to protect the ovarian reserve as the main components of PIK3 intracellular signaling pathway, affect the levels of hormones such as FSH, E2, and LH, which are ovarian reserve markers, and has negative effects on the histological structure of the ovary, oocyte morphology, and count. In the light of all these data obtained here, we believe that multiple and consecutive applications of KOH protocols might decrease the primordial follicle pool, which is the indicator of ovarian reserve and might bring the age of menopause forward.
Declaration of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Funding
This work was supported by the Gazi University Scientific Research Project (01/2017-14).
Author contribution statement
P S conducted the experiments, statistical analysis and wrote the manuscript. C E provided guidance and assisted with manuscript editing. F Y Performed gene expression and statistical analyses.
References
Accili D & Arden KC 2004 FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117 421–426. (https://doi.org/10.1016/s0092-8674(0400452-0)
Adhikari D, Flohr G, Gorre N, Shen Y, Yang H, Lundin E, Lan Z, Gambello MJ & Liu K 2009 Disruption of Tsc2 in oocytes leads to overactivation of the entire pool of primordial follicles. Molecular Human Reproduction 15 765–770. (https://doi.org/10.1093/molehr/gap092)
Adhikari D, Zheng W, Shen Y, Gorre N, Hämäläinen T, Cooney AJ, Huhtaniemi I, Lan ZJ & Liu K 2010 Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles. Human Molecular Genetics 19 397–410. (https://doi.org/10.1093/hmg/ddp483)
Alam H, Maizels ET, Park Y, Ghaey S, Feiger ZJ, Chandel NS & Hunzicker-Dunn M 2004 Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. Journal of Biological Chemistry 279 19431–19440. (https://doi.org/10.1074/jbc.M401235200)
Altunkaynak BZ, Akgül N, Yahyazadeh A, Altunkaynak ME, Turkmen AP, Akgül HM & Ünal B 2016 Effect of mercury vapor inhalation on rat ovary: stereology and histopathology. Journal of Obstetrics and Gynaecology Research 42 410–416. (https://doi.org/10.1111/jog.12911)
Cheong Y, Sadek KH, Bruce KD, Macklon N & Cagampang FR 2014 Diet-induced maternal obesity alters ovarian morphology and gene expression in the adult mouse offspring. Fertility and Sterility 102 899–907. (https://doi.org/10.1016/j.fertnstert.2014.06.015)
Chitnis SS, Selvaakumar C, Jagtap DD, Barnwal RP, Chary KV, Mahale SD & Nandedkar TD 2009 Interaction of follicle-stimulating hormone (FSH) receptor binding inhibitor-8: a novel FSH-binding inhibitor, with FSH and its receptor. Chemical Biology and Drug Design 73 637–643. (https://doi.org/10.1111/j.1747-0285.2009.00810.x)
Chuang CC, Chen CD, Chao KH, Chen SU, Ho HN & Yang YS 2003 Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertility and Sterility 79 63–68. (https://doi.org/10.1016/s0015-0282(0204562-4)
Eppig JJ 2001 Oocyte control of ovarian follicular development and function in mammals. Reproduction 122 829–838. (https://doi.org/10.1530/rep.0.1220829)
Gong Z, Shen X, Yang J, Yang K, Bai S & Wei S 2019 FSH receptor binding inhibitor up-regulates ARID1A and PTEN genes associated with ovarian cancers in mice. Brazilian Journal of Medical and Biological Research 52 e8381. (https://doi.org/10.1590/1414-431X20198381)
Gonzalez-Robayna IJ, Falender AE, Ochsner S, Firestone GL & Richards JS 2000 Follicle-stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells. Molecular Endocrinology 14 1283–1300. (https://doi.org/10.1210/mend.14.8.0500)
Goto M, Iwase A, Ando H, Kurotsuchi S, Harata T & Kikkawa F 2007 PTEN and Akt expression during growth of human ovarian follicles. Journal of Assisted Reproduction and Genetics 24 541–546. (https://doi.org/10.1007/s10815-007-9156-3)
Hobbs RJ, Howard J, Wildt DE & Comizzoli P 2012 Absence of seasonal changes in FSHR gene expression in the cat cumulus-oocyte complex in vivo and in vitro. Reproduction 144 111–122. (https://doi.org/10.1530/REP-12-0098)
Hsueh AJ, Kawamura K, Cheng Y & Fauser BC 2015 Intraovarian control of early folliculogenesis. Endocrine Reviews 36 1–24. (https://doi.org/10.1210/er.2014-1020)
Hunzicker-Dunn M & Maizels ET 2006 FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cellular Signalling 18 1351–1359. (https://doi.org/10.1016/j.cellsig.2006.02.011)
Ishibashi H, Suzuki T, Suzuki S, Moriya T, Kaneko C, Takizawa T, Sunamori M, Handa M, Kondo T & Sasano H 2003 Sex steroid hormone receptors in human thymoma. Journal of Clinical Endocrinology and Metabolism 88 2309–2317. (https://doi.org/10.1210/jc.2002-021353)
Jeppesen JV, Kristensen SG, Nielsen ME, Humaidan P, Dal Canto M, Fadini R, Schmidt KT, Ernst E & Andersen CY 2012 LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. Journal of Clinical Endocrinology and Metabolism 97 E1524–E1531. (https://doi.org/10.1210/jc.2012-1427)
Kalem Z, Kalem MN, Anado E, Bakırarar B, Yılmaz C, Elmas C, Yalçınkaya P, Ruso H & Gürgan T 2018 Maternal nutrition and reproductive functions of female and male offspring. Reproduction 156 353–364. (https://doi.org/10.1530/REP-18-0070)
Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, Wolf I, Kanety H, Sredni B & Meirow D 2013 Cyclophosphamide triggers follicle activation and ‘burnout’; AS101 prevents follicle loss and preserves. Fertility Science Translational Medicine 5 185–192. (https://doi.org/10.1126/scitranslmed.3005402)
Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA & Koff A 1996 Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85 721–732. (https://doi.org/10.1016/s0092-8674(0081238-6)
Li J, Kawamura K, Cheng Y, Liu S, Klein C, Liu S, Duan EK & Hsueh AJ 2010 Activation of dormant ovarian follicles to generate mature eggs. PNAS 107 10280–10284. (https://doi.org/10.1073/pnas.1001198107)
Liang L, Xu B & Zhu G 2009 Effect of repeated gonadotropin stimulation on ovarian reserves and proliferation of ovarian surface epithelium in mice. Frontiers of Medicine in China 3 220–226. (https://doi.org/10.1007/s11684-009-0037-2)
Maizels ET, Cottom J, Jones JC & Hunzicker-Dunn M 1998 Follicle stimulating hormone (FSH) activates the p38 mitogen-activated protein kinase pathway, inducing small heat shock protein phosphorylation and cell rounding in immature rat ovarian granulosa cells. Endocrinology 139 3353–3356. (https://doi.org/10.1210/endo.139.7.6188)
Marcondes FK, Bianchi FJ & Tanno AP 2002 Determination of the estrous cycle phases of rats: some helpful considerations. Brazilian Journal of Biology 62 609–614. (https://doi.org/10.1590/s1519-69842002000400008)
Minegishi T, Nakamura K, Takakura Y, Miyamoto K, Hasegawa Y, Ibuki Y, Igarashi M & Minegish T [corrected to Minegishi T] 1990 Cloning and sequencing of human LH/hCG receptor cDNA. Biochemical and Biophysical Research Communications 172 1049–1054. (https://doi.org/10.1016/0006-291x(9091552-4)
Minegishi T, Nakamura K, Takakura Y, Ibuki Y, Igarashi M & Minegish T [corrected to Minegishi T] 1991 Cloning and sequencing of human FSH receptor cDNA. Biochemical and Biophysical Research Communications 175 1125–1130. (https://doi.org/10.1016/0006-291x(9191682-3)
Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M & Grunfeld L 1996 An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertility and Sterility 65 588–593. (https://doi.org/10.1016/S0015-0282(1658159-X)
Myers M, Britt KL, Wreford NG, Ebling FJ & Kerr JB 2004 Methods for quantifying follicular numbers within the mouse ovary. Reproduction 127 569–580. (https://doi.org/10.1530/rep.1.00095)
Novella-Maestre E, Herraiz S, Rodríguez-Iglesias B, Diaz-Garcia C & Pellicer A 2015 Short-term PTEN inhibition improves in vitro activation of primordial follicles, preserves follicular viability, and restores AMH levels in cryopreserved ovarian tissue from cancer patients. PLoS ONE 10 e0127786. (https://doi.org/10.1371/journal.pone.0127786)
Ouyang JX, Luo T, Sun HY, Huang J, Tang DF, Wu L, Zheng YH & Zheng LP 2013 RNA interference mediated pten knock-down inhibit the formation of polycystic ovary. Molecular and Cellular Biochemistry 380 195–202. (https://doi.org/10.1007/s11010-013-1673-z)
Pan Z, Zhang J, Li Q, Li Y, Shi F, Xie Z & Liu H 2012 Current advances in epigenetic modification and alteration during mammalian ovarian folliculogenesis. Journal of Genetics and Genomics 39 111–123. (https://doi.org/10.1016/j.jgg.2012.02.004)
Quintana R, Kopcow L, Marconi G, Young E, Yovanovich C & Paz DA 2008 Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model. Fertility and Sterility 90 (Supplement) 1511–1516. (https://doi.org/10.1016/j.fertnstert.2007.09.028)
Richards JS, Sharma SC, Falender AE & Lo YH 2002 Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins. Molecular Endocrinology 16 580–599. (https://doi.org/10.1210/mend.16.3.0806)
Siristatidis C & Bhattacharya S 2007 Unexplained infertility: does it really exist? Does it matter? Human Reproduction 22 2084–2087. (https://doi.org/10.1093/humrep/dem117)
Skinner MK 2005 Regulation of primordial follicle assembly and development. Human Reproduction Update 11 461–471. (https://doi.org/10.1093/humupd/dmi020)
Tong W, Kiyokawa H, Soos TJ, Park MS, Soares VC, Manova K, Pollard JW & Koff A 1998 The absence of p27Kip1, an inhibitor of G1 cyclin-dependent kinases, uncouples differentiation and growth arrest during the granulosa luteal transition. Cell Growth and Differentiation 9 787–794.
Wang LQ, Liu JC, Chen CL, Cheng SF, Sun XF, Zhao Y, Yin S, Hou ZM, Pan B & Ding C et al.2016 Regulation of primordial follicle recruitment by cross-talk between the Notch and phosphatase and tensin homologue (PTEN)/AKT pathways. Reproduction, Fertility, and Development 28 700–712. (https://doi.org/10.1071/RD14212)
Xie JK, Wang Q, Zhang TT, Yin S, Zhang CL & Ge ZJ 2016 Repeated superovulation may affect mitochondrial functions of cumulus cells in mice. Scientific Reports 6 31368. (https://doi.org/10.1038/srep31368)
Yamoto M, Shima K & Nakano R 1992 Gonadotropin receptors in human ovarian follicles and corpora lutea throughout the menstrual cycle. Hormone Research 37 (Supplement 1) 5–11. (https://doi.org/10.1159/000182335)
Yu FQ, Han CS, Yang W, Jin X, Hu ZY & Liu YX 2005 Activation of the p38 MAPK pathway by follicle-stimulating hormone regulates steroidogenesis in granulosa cells differentially. Journal of Endocrinology 186 85–96. (https://doi.org/10.1677/joe.1.05955)
Zhang M, Shi H, Segaloff DL & Van Voorhis BJ 2001 Expression and localization of luteinizing hormone receptor in the female mouse reproductive tract. Biology of Reproduction 64 179–187. (https://doi.org/10.1093/biolreprod/64.1.179)